nortriptyline has been researched along with Liver Steatosis in 1 studies
Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, Q | 2 |
| An, J | 2 |
| Liu, P | 2 |
| Song, Y | 2 |
| Zhai, X | 2 |
| Yang, R | 2 |
| Niu, J | 2 |
| Yang, C | 2 |
| Li, B | 2 |
1 other study available for nortriptyline and Liver Steatosis
| Article | Year |
|---|---|
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
Topics: Animals; Antidepressive Agents, Tricyclic; Drug Repositioning; Fatty Acids; Fatty Liver; Liver; Meta | 2023 |
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
Topics: Animals; Antidepressive Agents, Tricyclic; Drug Repositioning; Fatty Acids; Fatty Liver; Liver; Meta | 2023 |
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
Topics: Animals; Antidepressive Agents, Tricyclic; Drug Repositioning; Fatty Acids; Fatty Liver; Liver; Meta | 2023 |
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
Topics: Animals; Antidepressive Agents, Tricyclic; Drug Repositioning; Fatty Acids; Fatty Liver; Liver; Meta | 2023 |